Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hodgkin disease
Phenotype C0019158|hepatitis
Sentences 9
PubMedID- 21188204 In a recently published review of 160 chronic hepatitis c patients with non-hodgkin lymphoma, twenty-four (15%) of them developed significant liver toxicity during chemotherapy [14].
PubMedID- 21696249 We describe a case of severe acute hepatitis b developing in a patient with hodgkin's lymphoma after chemotherapy and before radiotherapy.
PubMedID- 20876592 Objective: to evaluate clinical and biological surrogate markers associated with the presence of b cell non-hodgkin's lymphoma (b-nhl) in patients with hepatitis c virus (hcv) with mixed cryoglobulinaemia (mc) vasculitis.
PubMedID- 25158783 Telomeric 1p36.3 deletion and ki-67 expression in b-non-hodgkin's lymphoma patients associated with chronic hepatitis c virus infection.
PubMedID- 20554488 Hcv-positive status and hepatitis flares in patients with b-cell non-hodgkin's lymphoma treated with rituximab-containing regimens.
PubMedID- 20610938 [icteric hepatitis in a patient with non-hodgkin's lymphoma treated by rituximab-based chemotherapy].
PubMedID- 24060287 Bendamustine and rituximab for indolent b-cell non-hodgkin lymphoma in patients with compensated hepatitis c cirrhosis: a case series.
PubMedID- 24367885 hepatitis b reactivation in patient with non-hodgkin's lymphoma receiving rituximab-based chemotherapy: need for education and attention.
PubMedID- 23082489 Genetic profiling of non-hodgkin's lymphoma with or without hepatitis c virus infection.

Page: 1